Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab + Preoperative Radiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma
NCT02123381Phase 2Unknown
- Sponsor
- Sichuan Cancer Hospital
- Start
- Apr 2014
- Primary completion
- Jul 2020
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of KL-140 in Esophageal Squamous Cell Carcinoma (ESCC), sponsored by Sichuan Cancer Hospital. Status: unknown.
02
Drugs
KL-140
03
Conditions
Esophageal Squamous Cell Carcinoma (ESCC)
Beyond the preview
Go deeper on NCT02123381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02123381.